CYTK - CYTOKINETICS INC

QQQ $ 475.46 $ -7.65 (-1.59 %)

DIA $ 407.51 $ -1.51 (-0.37 %)

SPY $ 556.52 $ -4.40 (-0.78 %)

TLT $ 97.74 $ -0.98 (-0.99 %)

GLD $ 229.39 $ -2.78 (-1.2 %)

Previous Close

$ 56.25

Open

Bid

$ 55.70 x 2,900

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 25.98 - $ 110.25

Volume

837,974

Average Volume

Market Cap

6.62B

Beta (5Y Monthly)

$ 0.93

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-09-2024	06-30-2024	10-Q
2	05-10-2024	03-31-2024	10-Q
3	02-28-2024	12-31-2023	10-K
4	11-03-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-05-2023	03-31-2023	10-Q
7	03-01-2023	12-31-2022	10-K
8	11-04-2022	09-30-2022	10-Q
9	08-05-2022	06-30-2022	10-Q
10	05-06-2022	03-31-2022	10-Q
11	02-25-2022	12-31-2021	10-K
12	11-05-2021	09-30-2021	10-Q
13	08-06-2021	06-30-2021	10-Q
14	05-07-2021	03-31-2021	10-Q
15	02-26-2021	12-31-2020	10-K
16	11-06-2020	09-30-2020	10-Q
17	08-10-2020	06-30-2020	10-Q
18	05-08-2020	03-31-2020	10-Q
19	03-04-2020	12-31-2019	10-K
20	11-01-2019	09-30-2019	10-Q
21	08-09-2019	06-30-2019	10-Q
22	05-09-2019	03-31-2019	10-Q
23	03-07-2019	12-31-2018	10-K
24	11-09-2018	09-30-2018	10-Q
25	08-07-2018	06-30-2018	10-Q
26	05-10-2018	03-31-2018	10-Q
27	03-05-2018	12-31-2017	10-K
28	11-03-2017	09-30-2017	10-Q
29	08-04-2017	06-30-2017	10-Q
30	05-04-2017	03-31-2017	10-Q
31	03-06-2017	12-31-2016	10-K
32	11-03-2016	09-30-2016	10-Q
33	08-04-2016	06-30-2016	10-Q
34	05-05-2016	03-31-2016	10-Q
35	03-03-2016	12-31-2015	10-K
36	11-05-2015	09-30-2015	10-Q
37	08-05-2015	06-30-2015	10-Q
38	05-04-2015	03-31-2015	10-Q
39	03-06-2015	12-31-2014	10-K
40	11-06-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Goldman Sachs Downgrades Cytokinetics to N...
08/13/2024 09:13:58

Goldman Sachs analyst Paul Choi downgrades Cytokinetics (NASDAQ:CYTK) from Buy to Neutral and lowers the price target from $...

HC Wainwright & Co. Reiterates Buy on Cyto...
08/12/2024 10:10:50

HC Wainwright & Co. analyst Joseph Pantginis reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $90 price ta...

Needham Reiterates Buy on Cytokinetics, Ma...
08/09/2024 21:04:52

Needham analyst Serge Belanger reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $72 price target.

Cytokinetics Q2 2024 GAAP EPS $(1.31) Miss...
08/08/2024 20:42:41

Cytokinetics (NASDAQ:CYTK) reported quarterly losses of $(1.31) per share which missed the analyst consensus estimate of $(1.02...

JP Morgan Maintains Overweight on Cytokine...
06/24/2024 11:56:27

JP Morgan analyst Tessa Romero maintains Cytokinetics (NASDAQ:CYTK) with a Overweight and lowers the price target from $77 t...

HC Wainwright & Co. Reiterates Buy on Cyto...
06/17/2024 14:55:09

HC Wainwright & Co. analyst Joseph Pantginis reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $90 price ta...

Cytokinetics Has Dosed The First Participa...
06/17/2024 11:32:09

peering-into-cytokineticss-recent-short-interest

Peering Into Cytokinetics's Recent Short I...
06/07/2024 16:45:14

Cytokinetics Engaged In Acquisition Talks ...
06/05/2024 14:06:21

B. Riley Securities Maintains Buy on Cytok...
06/04/2024 16:47:35

B. Riley Securities analyst Mayank Mamtani maintains Cytokinetics (NASDAQ:CYTK) with a Buy and lowers the price target from ...

JMP Securities Reiterates Market Outperfor...
05/31/2024 15:29:48

JMP Securities analyst Jason Butler reiterates Cytokinetics (NASDAQ:CYTK) with a Market Outperform and maintains $78 price t...

Truist Securities Maintains Buy on Cytokin...
05/29/2024 12:53:12

Truist Securities analyst Srikripa Devarakonda maintains Cytokinetics (NASDAQ:CYTK) with a Buy and lowers the price target f...

JMP Securities Maintains Market Outperform...
05/28/2024 16:10:21

JMP Securities analyst Jason Butler maintains Cytokinetics (NASDAQ:CYTK) with a Market Outperform and lowers the price targe...

dow-dips-over-550-points-bjs-wholesale-club-earnings-beat-views

Dow Dips Over 550 Points; BJ's Wholesale C...
05/23/2024 18:40:33

heart-disease-focused-cytokinetics-operations-are-on-track-despite-acquisition-uncertainty-analysts-observe

Heart Disease-Focused Cytokinetics Operati...
05/23/2024 18:30:40

Unlock the latest on Royalty Pharma plc & Cytokinetics Inc.'s strategic funding collaboration for aficamten's comme...

8-health-care-stocks-whale-activity-in-todays-session

8 Health Care Stocks Whale Activity In Tod...
05/23/2024 17:35:21

HC Wainwright & Co. Maintains Buy on Cytok...
05/23/2024 17:03:16

HC Wainwright & Co. analyst Joseph Pantginis maintains Cytokinetics (NASDAQ:CYTK) with a Buy and lowers the price target...

B of A Securities Maintains Neutral on Cyt...
05/23/2024 16:55:39

B of A Securities analyst Jason Zemansky maintains Cytokinetics (NASDAQ:CYTK) with a Neutral and lowers the price target fro...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
05/23/2024 16:31:11

gold-falls-sharply-us-composite-pmi-surges-in-may

Gold Falls Sharply; US Composite PMI Surge...
05/23/2024 16:01:36